News for '-us-federal-trade-commission'

Regulate Big Tech's AI Now!

Regulate Big Tech's AI Now!

Rediff.com21 Mar 2024

Regulators must learn from past mistakes and act swiftly to prevent Big Tech from monopolising the AI ecosystem, argue Payal Malik and Nikita Jain.

Sun Pharma gets US FTC nod for Taro open offer

Sun Pharma gets US FTC nod for Taro open offer

Rediff.com14 Aug 2008

In a filing to the Bombay Stock Exchange, Sun Pharma said the US Federal Trade Commission (FTC) has granted early termination of the anti-trust waiting period for the previously announced tender offer by its subsidiary Alkaloida Chemical Company Exclusive Group Ltd. Last month the Mumbai-based firm had launched an open offer at a price of $7.75 per share to acquire all outstanding shares of Taro, including all of the founders' shares.

Is the Facebook-WhatsApp deal under threat?

Is the Facebook-WhatsApp deal under threat?

Rediff.com7 Mar 2014

WhatsApp has stated that it does not intend to collect user data for advertising purposes.

Intel settles charges of anti-competitive conduct

Intel settles charges of anti-competitive conduct

Rediff.com5 Aug 2010

Global computer chip major Intel has reached at a settlement with the US Federal Trade Commission to resolve the anti-competitive charges against it and agreed to follow series of restrictions.

 FTC concerned about Google's proposed AdMob buy

FTC concerned about Google's proposed AdMob buy

Rediff.com7 Apr 2010

The US Federal Trade Commission is understood to be preparing for an antitrust challenge against Internet giant Google's proposed purchase of mobile advertising firm AdMob, a media report says.

Sun Pharma gets US trade regulator nod for Ranbaxy deal

Sun Pharma gets US trade regulator nod for Ranbaxy deal

Rediff.com2 Feb 2015

Ranbaxy was asked to sell all products containing Leuprorelin which are marketed and supplied under brand name Eligard.

Sun-Ranbaxy merger may spill over to 2015

Sun-Ranbaxy merger may spill over to 2015

Rediff.com15 Nov 2014

The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.

The many battles that Amazon is fighting in India

The many battles that Amazon is fighting in India

Rediff.com8 Jul 2021

Among all the geographies where Amazon is fighting regulators, India is the only place where its lines are also tangled in a major corporate battle, this one with India's largest company by market capitalisation over the acquisition of Mumbai-based Future Group's retail chain, the country's second largest. No other corporate entity in any country offers a challenge to Amazon's hegemony in a way Reliance Industries does - and the final hearing of an arbitration case filed at the Singapore International Arbitration Centre between the two may decide at least some of these issues. This legal battle between one of the world's most powerful corporations and one of India's most powerful conglomerates could be complicated by a host of other developments.

Should Facebook be broken up to ensure data safety?

Should Facebook be broken up to ensure data safety?

Rediff.com15 May 2019

The fears arise from Facebook's handling of user data and potential privacy violations, more specifically the Cambridge Analytica scandal.

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Rediff.com13 Jun 2016

The combined sales of the branded versions of the products in the US is about $3.5 billion.

Sun-Ranbaxy merger clears last hurdle

Sun-Ranbaxy merger clears last hurdle

Rediff.com10 Mar 2015

On January 31, the US Federal Trade Commission cleared the merger.

Wall Street slides as oil prices tumble to near 7-year low

Wall Street slides as oil prices tumble to near 7-year low

Rediff.com8 Dec 2015

The major US indexes pared losses late in the session.

Ranbaxy brand may fade away as Sun takes charge

Ranbaxy brand may fade away as Sun takes charge

Rediff.com10 Dec 2014

The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.

Markets extend gains for the fourth straight day

Markets extend gains for the fourth straight day

Rediff.com22 Feb 2016

The S&P BSE Sensex ended 80 points up at 23,789 while the Nifty50 closed at 7,235, up 24 points.

BJP, Cong accuse each other of hiring firm linked to FB data breach

BJP, Cong accuse each other of hiring firm linked to FB data breach

Rediff.com21 Mar 2018

The minister also cautioned the social media giant and its CEO Mark Zuckerberg of repercussions under the IT Act in case of any data breach came to light.

Why only Maggi, authority must tighten noose around other brands too

Why only Maggi, authority must tighten noose around other brands too

Rediff.com8 Jun 2015

Apart from Maggi noodles, many other products can be tested for health issues.

The woman who is giving Google sleepless nights

The woman who is giving Google sleepless nights

Rediff.com17 Apr 2015

In EU Competition Commissioner Margrethe Vestager, who has kickstarted the long-pending anti-trust investigation into Google, the internet search giant may have finally met its match.

Sun gets US trade regulator nod for Ranbaxy merger

Sun gets US trade regulator nod for Ranbaxy merger

Rediff.com1 Feb 2015

Torrent to buy Ranbaxy's anti-bacterial generic

Has India's anti-trust watchdog lost its drive?

Has India's anti-trust watchdog lost its drive?

Rediff.com20 May 2016

The number of cases being admitted and investigated by the Competition Commission of India has fallen drastically in recent years.

The Huge Call Centre Scam

The Huge Call Centre Scam

Rediff.com20 Oct 2016

An industry of scamsters is operating in the guise of call centres in India.